NT-I7 promotes longer survival in murine models of glioma through CD8+ T cells Jan. 19, 2022 No Comments
Ortho-hIL-2/ortho-hIL-2Rbeta pair enhances antitumor efficacy of engineered T cells Jan. 19, 2022 No Comments
[225Ac]OTSA-101 confers complete remission in preclinical model of synovial sarcoma Jan. 14, 2022 No Comments
Antibodies against SIRPA and SIRPB1 promote antitumoral effect in preclinical study Jan. 14, 2022 No Comments
Hemogenyx and Selexis agree to develop cell line for Hemogenyx's CDX bispecific antibody Jan. 13, 2022 No Comments
Neogene licenses portfolio of TCRs targeting KRAS and TP53 mutations from NCI Jan. 12, 2022 No Comments
Dren Bio and Pfizer collaborate to discover and develop bispecific antibodies for cancer Jan. 12, 2022 No Comments
RSS